BCHE and Parkinson disease: While both isoforms were predicted to be soluble and localize to the extracellular space, the shorter isoform lacks the substrate binding site located at positions 144 and 145 and it is therefore predicted to be non-functional, suggesting that BCHE function may be down-regulated in PD.